ITE and TCDD differentially regulate the vascular remodeling of rat placenta via the activation of AhR

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Wu, Yanming ^a   Chen, Xiao ^a   Zhou, Qian ^a   He, Qizhi ^a   Kang, Jiuhong ^a,b   Zheng, Jing ^c   Wang, Kai ^a   Duan, Tao ^a  

^a Shanghai First Maternity and Infant Health Hospital   (China)

^b TONGJI UNIVERSITY   (China)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (1' H INDOLE 3' CARBONYL)THIAZOLE 4 CARBOXYLIC ACID METHYL ESTER; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANGIOPOIETIN 2; AROMATIC HYDROCARBON RECEPTOR; CD31 ANTIGEN; ENDOGLIN; ENVIRONMENTAL CHEMICAL; GAMMA INTERFERON; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; 2-(1'H-INDOLE-3'-CARBONYL)THIAZOLE-4-CARBOXYLIC ACID METHYL ESTER; 2-HYDROXY-1,3,7,8-TETRACHLORODIBENZO-4-DIOXIN; ENDOGLIN PROTEIN, RAT; INDOLE DERIVATIVE; PLACENTA PROTEIN; POLLUTANT; SIGNAL PEPTIDE; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS DEATH; FETUS WEIGHT; NONHUMAN; PLACENTA; PLACENTA CIRCULATION; PLACENTA WEIGHT; PRENATAL DRUG EXPOSURE; RAT; TROPHOBLAST; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; FETUS; GENE EXPRESSION; GENETICS; METABOLISM; POLLUTANT; PREGNANCY; TOXICITY; VASCULAR REMODELING; VASCULARIZATION;

ANGIOPOIETIN-2; ANIMALS; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL DEATH; FETUS; GENE EXPRESSION; INDOLES; INTERFERON-GAMMA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; RATS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; THIAZOLES; VASCULAR REMODELING;

EID: 84899813910     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086549     Document Type: Article

References (41)

1. Wulff C, Weigand M, Kreienberg R, Fraser HM (2003) Angiogenesis during primate placentation in health and disease. Reproduction 126: 569-77. (Pubitemid 37540616)
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376: 631-44.
3. He W, Greenwell RJ, Brooks DM, Calderon-Garciduenas L, Beall HD, et al. (2007) Arsenic exposure in pregnant mice disrupts placental vasculogenesis and causes spontaneous abortion. Toxicol Sci 99: 244-53. (Pubitemid 47250382)
4. Eskenazi B, Kimmel G (1995) Workshop on perinatal exposure to dioxin-like compounds. II. Reproductive effects. Environ Health Perspect 103 Suppl 2: 143-45.
5. Reynolds LP, Redmer DA (1995) Utero-placental vascular development and placental function. J Anim Sci 73: 1839-51.
6. Emond C, Birnbaum LS, DeVito MJ (2004) Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat. Toxicol Sci 80: 115-33. (Pubitemid 38967404)
7. Ishimura R, Kawakami T, Ohsako S, Tohyama C (2009) Dioxin-induced toxicity on vascular remodeling of the placenta. Biochem Pharmacol 77: 660-69.
8. Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD (2003) Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 110 Suppl 1: S10-18. (Pubitemid 37074857)
9. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-95.
10. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9: 669-76. (Pubitemid 36749215)
11. Andraweera PH, Dekker GA, Roberts CT (2012) The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update 18: 436-57.
12. Jiang YZ, Wang K, Fang R, Zheng J (2010) Expression of aryl hydrocarbon receptor in human placentas and fetal tissues. J Histochem Cytochem 58: 679-85.
13. Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, et al. (2000) Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci U S A 97: 10442-47.
14. Pocar P, Fischer B, Klonisch T, Hombach-Klonisch S (2005) Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 129: 379-89. (Pubitemid 40542164)
15. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279: 23847-50. (Pubitemid 38725238)
16. Henry EC, Bemis JC, Henry O, Kende AS, Gasiewicz TA (2006) A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Arch Biochem Biophys 450: 67-77. (Pubitemid 43782737)
17. Ivnitski-Steele ID, Walker MK (2003) Vascular endothelial growth factor rescues 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibition of coronary vasculogenesis. Birth Defects Res A Clin Mol Teratol 67: 496-503. (Pubitemid 37238037)
18. Mizutani T, Yoshino M, Satake T, Nakagawa M, Ishimura R, et al. (2004) Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible and - suppressive genes in the rat placenta: induction of interferon-regulated genes with possible inhibitory roles for angiogenesis in the placenta. Endocr J 51: 569-77. (Pubitemid 40209025)
19. Ishimura R, Ohsako S, Kawakami T, Sakaue M, Aoki Y, et al. (2002) Altered protein profile and possible hypoxia in the placenta of 2,3,7,8-tetrachlorodi- benzo- p-dioxin-exposed rats. Toxicol Appl Pharmacol 185: 197-206. (Pubitemid 36062793)
20. Ivnitski-Steele I, Walker MK (2005) Inhibition of neovascularization by environmental agents. Cardiovasc Toxicol 5: 215-26. (Pubitemid 41058633)
21. Ishimura R, Kawakami T, Ohsako S, Nohara K, Tohyama C (2006) Suppressive effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vascular remodeling that takes place in the normal labyrinth zone of rat placenta during late gestation. Toxicol Sci 91: 265-74.
22. Song J, Clagett-Dame M, Peterson RE, Hahn ME, Westler WM, et al. (2002) A ligand for the aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci U S A 99: 14694-99. (Pubitemid 35334546)
23. Henry EC, Welle SL, Gasiewicz TA (2010) TCDD and a putative endogenous AhR ligand, ITE, elicit the same immediate changes in gene expression in mouse lung fibroblasts. Toxicol Sci 114: 90-100.
24. Quintana FJ, Murugaiyan G, Farez MF, Mitsdoerffer M, Tukpah AM, et al. (2010) An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 107: 20768-73.
25. Kawakami T, Ishimura R, Nohara K, Takeda K, Tohyama C, et al. (2006) Differential susceptibilities of Holtzman and Sprague-Dawley rats to fetal death and placental dysfunction induced by 2,3,7,8-teterachlorodibenzo-p-dioxin (TCDD) despite the identical primary structure of the aryl hydrocarbon receptor. Toxicol Appl Pharmacol 212: 224-36.
26. Furukawa S, Hayashi S, Usuda K, Abe M, Hagio S, et al. (2011) Toxicological pathology in the rat placenta. J Toxicol Pathol 24: 95-111.
27. Chantraine F, Blacher S, Berndt S, Palacios-Jaraquemada J, Sarioglu N, et al. (2012) Abnormal vascular architecture at the placental-maternal interface in placenta increta. Am J Obstet Gynecol 207: 181-88.
28. Nguyen LP, Bradfield CA (2008) The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21: 102-16. (Pubitemid 351219712)
29. Stevens EA, Mezrich JD, Bradfield CA (2009) The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 127: 299-311.
30. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-32.
31. Patel J, Landers K, Mortimer RH, Richard K (2010) Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development. Placenta 31: 951-57.
32. Terzuoli E, Puppo M, Rapisarda A, Uranchimeg B, Cao L, et al. (2010) Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion. Cancer Res 70: 6837-48.
33. Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, et al. (2003) Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93: 664-73. (Pubitemid 37222163)
34. Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677-84. (Pubitemid 36749216)
35. Dewerchin M, Carmeliet P (2012) PlGF: a multitasking cytokine with diseaserestricted activity. Cold Spring Harb Perspect Med 2.
36. Goldman-Wohl DS, Ariel I, Greenfield C, Lavy Y, Yagel S (2000) Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling. Mol Hum Reprod 6: 81-87. (Pubitemid 30043593)
37. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60. (Pubitemid 27450643)
38. Lobov IB, Brooks PC, Lang RA (2002) Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A 99: 11205-10. (Pubitemid 34920903)
39. Pichiule P, LaManna JC (2002) Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia. J Appl Physiol 93: 1131-39. (Pubitemid 34919687)
40. Gilbert JS, Gilbert SA, Arany M, Granger JP (2009) Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53: 399-403.
41. Laug R, Fehrholz M, Schutze N, Kramer BW, Krump-Konvalinkova V, et al. (2012) IFN-gamma and TNF-alpha synergize to inhibit CTGF expression in human lung endothelial cells. PLoS One 7: e45430.